Mandate

Vinge advises Aller Media in two acquisitions

June 28, 2011

Vinge has advised Aller Media in conjunction with the acquisition of Modegallerian.se. The intention is to make the site the country’s largest online fashion gallery. The transaction entails that Aller will be the majority shareholder. The seller is Slash 8 Media Group.

Vinge also advised Aller Media in connection with the expansion of its magazine portfolio with three new titles: Mat & Vänner, Baka and Mat & Vänner Vin. In addition to the magazines, Aller Media also acquired a customer magazine holding and significant book publications primarily consisting of food and cook books. The seller is Food & Wine Publishing Group in Helsingborg.

Aller Media currently publishes 40 publications, including the food magazines Matmagasinet and ELLE Mat & Vin. Editorial offices are located in Stockholm, Gothenburg, Malmö and Helsingborg. Aller Media has 550 employees and its turnover in 2010 was SEK 1.6 billion. The head office is located in Helsingborg.

Vinge’s team consisted of responsible partner Henrik Borna together with, among others, associates Anna Edström, Ida Christensson and Therese Lindholm.

 

Related

Vinge has advised Hansa Biopharma in connection with entering into a financing agreement

Vinge has advised Hansa Biopharma AB (publ), a commercial-stage biopharmaceutical company on a mission to develop and commercialize innovative, lifesaving and life-altering treatments for patients with rare immunological conditions, listed on Nasdaq Stockholm, in connection with a U.S. convertible note purchase agreement comprising USD 30 million aggregate principal amount of unsecured convertible senior notes.
March 23, 2026

Vinge advises in connection with data center provider EcoDataCenter’s tap issue of SEK 500 million bonds

Vinge has advised in connection with EcoDC Holding AB (publ)'s tap issue of SEK 500 million senior unsecured bonds under the existing framework of up to SEK 2 billion.
March 19, 2026

Vinge has advised Cinclus Pharma in connection with entering into financing agreement

Vinge has advised Cinclus Pharma Holding AB (publ), a late-stage clinical pharmaceutical company developing next-generation treatments for gastric acid-related diseases listed on Nasdaq Stockholm, in connection with a long-term structured credit agreement for a total of up to EUR 28 million divided into four tranches, of which two are convertibles.
March 16, 2026